⚡Bharat Biotech to Conduct Phase-3 Trials of Covaxin in 26,000 Volunteers
By PTI
The city-based vaccine maker had on October 2 sought the Drug Controller General of India (DCGI)'s permission to conduct Phase 3 randomised double-blind placebo-controlled multi centre trial of its COVID-19 vaccine, sources said.